U.S. FDA approves Amgen drug for prevention of migraines

(Reuters) – Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in adults.

Leave a Reply

Your email address will not be published. Required fields are marked *